Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Agustini

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
JAMA|November 7, 2018
Medications With Depression as an Adverse EffectBruno Agustini, Michael Berk
The Australian and New Zealand Journal of Psychiatry|July 23, 2019
The open access mandate: Be careful what you wish forBruno Agustini, Michael Berk
The Lancet. Psychiatry|February 9, 2020
The embryology of psychosisBruno Agustini, Michael Berk
Journal of Affective Disorders|November 19, 2017
Atypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic reviewMario F Juruena, Mariia Bocharova, Bruno Agustini, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|May 3, 2019
Co-occurrence of depression with chronic diseases among the older population living in low- and middle-income countries: A compound health challengeMojtaba Lotfaliany, Bruno Agustini, Paul Kowal, et al.
Stem Cell Investigation|March 10, 2017
A translational approach to clinical practice via stress-responsive glucocorticoid receptor signalingMario F Juruena, Bruno Agustini, Anthony J Cleare, et al.
Drugs & Aging|April 29, 2021
Major Depressive Disorder in Older Patients as an Inflammatory Disorder: Implications for the Pharmacological Management of Geriatric DepressionMalcolm P Forbes, Adrienne O'Neil, Melissa Lane, et al.
Journal of Affective Disorders|July 13, 2019
Has the sun set for seasonal affective disorder and HPA axis studies? A systematic review and future prospectsBruno Agustini, Mariia Bocharova, Adam J Walker, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 22, 2024
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023: Towards Personalized Approaches to Depression TreatmentMichael Berk, Bruno Agustini, Malcolm Forbes, et al.
Frontiers in Psychiatry|September 26, 2019
Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric DisordersRickinder Sethi, Nieves Gómez-Coronado, Adam J Walker, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
JAMA|November 7, 2018
Medications With Depression as an Adverse EffectBruno Agustini, Michael Berk
The Australian and New Zealand Journal of Psychiatry|July 23, 2019
The open access mandate: Be careful what you wish forBruno Agustini, Michael Berk
The Lancet. Psychiatry|February 9, 2020
The embryology of psychosisBruno Agustini, Michael Berk
Journal of Affective Disorders|November 19, 2017
Atypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic reviewMario F Juruena, Mariia Bocharova, Bruno Agustini, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|May 3, 2019
Co-occurrence of depression with chronic diseases among the older population living in low- and middle-income countries: A compound health challengeMojtaba Lotfaliany, Bruno Agustini, Paul Kowal, et al.
Stem Cell Investigation|March 10, 2017
A translational approach to clinical practice via stress-responsive glucocorticoid receptor signalingMario F Juruena, Bruno Agustini, Anthony J Cleare, et al.
Drugs & Aging|April 29, 2021
Major Depressive Disorder in Older Patients as an Inflammatory Disorder: Implications for the Pharmacological Management of Geriatric DepressionMalcolm P Forbes, Adrienne O'Neil, Melissa Lane, et al.
Journal of Affective Disorders|July 13, 2019
Has the sun set for seasonal affective disorder and HPA axis studies? A systematic review and future prospectsBruno Agustini, Mariia Bocharova, Adam J Walker, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 22, 2024
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023: Towards Personalized Approaches to Depression TreatmentMichael Berk, Bruno Agustini, Malcolm Forbes, et al.
Frontiers in Psychiatry|September 26, 2019
Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric DisordersRickinder Sethi, Nieves Gómez-Coronado, Adam J Walker, et al.
Pageof 4